I keep hitting the buy button on Salesforce (NYSE:CRM | CRM Price Prediction), and I am not sorry about it. The stock sits at $152.76, down 42.03% year to date and 43.18% over the…
SpaceX (NASDAQ:SPCX | SPCX Price Prediction) and Tesla (NASDAQ:TSLA) sit on opposite sides of the same Elon Musk story. SpaceX debuted on June 12 and carries a $2.13 trillion market cap. Tesla closed Q1…
A 66-year-old with $1.3 million can’t afford a dividend cut. The hunt for yield often pushes retirees into mega-caps, but I think the real income value sits in mid-caps whose GAAP earnings are masked…
Republic Services (NYSE:RSG | RSG Price Prediction) is a stock built to be owned for decades, because it sits at the intersection of a non-discretionary service economy and a pricing model that compounds quietly…
I hit the buy button on AbbVie (NYSE:ABBV | ABBV Price Prediction) again last week, and I will hit it again the next time June’s macro noise hands me a discount. While short-term traders…
Air Products & Chemicals (NYSE:APD | APD Price Prediction) is a stock worth owning for decades because it sells an essential, contractually locked-in product into every corner of the global industrial economy and has…
S&P Global (NYSE:SPGI | SPGI Price Prediction) screens as a multi-decade compounder candidate because it operates a legally protected toll booth on global capital markets that almost every borrower, asset manager, and index fund…
At $381.61, Tesla (NASDAQ:TSLA | TSLA Price Prediction) looks vulnerable, with a credible path toward the $190 historical manufacturing support zone as tech multiples compress and global EV pricing grinds margins lower. The stock…
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) is a stock with characteristics suited to multi-decade ownership, because its four-segment healthcare engine, 54 consecutive years of dividend increases, and recession-resistant end markets give a retirement-focused…
At 60 with $800,000, the goal is yield without sleepless nights. Capital costs are climbing again, which squeezes any dividend payer that leans on debt markets. This analysis runs a margin-of-safety check on four…
Rivian (NASDAQ:RIVN | RIVN Price Prediction) at $14.89 is a Hold, with fresh capital best reserved unless a broader sector panic drags the equity toward $11.50. The stock has slid 24.45% year to date…
I keep buying Coca-Cola while half of Wall Street treats every consumer staple like it has a fuse on it. The June panic over a softening jobs report, decelerating GDP growth, and credit card…
At 64, with $1.1 million in a Traditional IRA, tax-deferred cash flow is the point. With the 10-year Treasury at 4.50% and the 30-year at 4.94%, dividend yields have to earn their seat. The…
I keep hitting the buy button on Adobe (NASDAQ:ADBE | ADBE Price Prediction) because the market has handed me a chance to own a global software franchise at a multiple normally reserved for a…
I keep buying ASML (NASDAQ:ASML | ASML Price Prediction), and every time Wall Street has a fresh panic attack about 4.2% inflation, I find another reason to hit the button again. The macro crowd…
Mastercard (NYSE:MA | MA Price Prediction) is a stock worth owning for decades because it sits inside a global payments duopoly that takes a small, recurring toll on a rising tide of digital transactions…
Hormel Foods has been in a slow-motion bear hug. The stock sits 22.8% below its 52-week high, and the trailing GAAP payout ratio looks ugly after a $234 million non-cash impairment and a $61…
Oracle has been my focus this month, and the recent selloff has only sharpened that focus. The stock has dropped 29.45% since June 1, the financial press is hyperventilating about cash burn, and my…
Everyone is still arguing about Novo Nordisk (NYSE:NVO | NVO Price Prediction), the Danish obesity juggernaut whose GLP-1 franchise turned Wegovy and Ozempic into household names and dragged the entire pharma sector into a…
Amazon (NASDAQ:AMZN | AMZN Price Prediction) is a stock worth owning for the next two decades because three high-margin engines, AWS, advertising, and Prime subscriptions, now compound on top of a retail base that…
